612 results on '"Verspaget, Hein. W."'
Search Results
152. Neutralizing antibodies against adeno-associated viruses in inflammatory bowel disease patients: Implications for gene therapy
153. Pretreatment with Interferon-γ Enhances the Therapeutic Activity of Mesenchymal Stromal Cells in Animal Models of Colitis
154. Symptoms in patients with ulcerative colitis in remission are associated with visceral hypersensitivity and mast cell activity
155. Pretreatment With Interferon-Gamma Enhances the Therapeutic Activity of Mesenchymal Stromal Cells in Animal Models of Colitis
156. Neutralizing Antibodies Against Adeno-Associated Viruses (AAV) in Inflammatory Bowel Disease Patients: Implications for Gene Therapy
157. A Functional Variant of the Farnesoid X Receptor (FXR) Predisposes to Ileocolonic Localization of Crohn's Disease
158. The Protease Genes Cyld and USP40 Are Associated With Crohn's Disease: Results From a European Consortium
159. 5-ASA Inhibits Phospolipase D-Dependent Mammalian Target of Rapamycin Signaling in Colorectal Cancer
160. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
161. Pathological Incidence of Duodenopancreatic Neuroendocrine Tumors in The Netherlands
162. Lectin complement pathway gene profile of donor and recipient determine the risk of bacterial infections after orthotopic liver transplantation
163. Matrix Metalloproteinase-14 (MT1-MMP)–Mediated Endoglin Shedding Inhibits Tumor Angiogenesis
164. M1190 5-Aminosalicylic Acid Induces Colorectal Cancer Cell Death In Vitro and In Vivo
165. 337 Donor and Recipient Lectin Complement Pathway Genes Determine the Risk of Clinically Significant Infections After Orthotopic Liver Transplantation
166. 5-aminosalicylic acid interferes in the cell cycle of colorectal cancer cells and induces cell death modes
167. Corrigendum: Genetic Analysis in A Dutch Study Sample Identifies More Ulcerative Colitis Susceptibility Loci and Shows Their Additive Role in Disease Risk
168. Genetic Analysis in A Dutch Study Sample Identifies More Ulcerative Colitis Susceptibility Loci and Shows Their Additive Role in Disease Risk
169. Toward MSC in Solid Organ Transplantation: 2008 Position Paper of the MISOT Study Group
170. T1690 Visceroperception in Patients with Ulcerative Colitis; Role of Colorectal Mast Cells
171. S1958 The Gly82ser Polymorphism of RAGE Is Not Associated with Gastric or Colorectal Cancer in a Western Population
172. 50 5-Aminosalicylic Acid Suppresses Colitis-Associated But Not Sporadic Colorectal Cancer
173. Matrix metalloproteinases and their tissue inhibitors as prognostic indicators for diagnostic and surgical recurrence in Crohnʼs disease
174. DNA Copy-Number Alterations Underlie Gene Expression Differences between Microsatellite Stable and Unstable Colorectal Cancers
175. MMP-2 and MMP-9 Serum Levels Change but their Gene Promoter Polymorphisms are not Associated with Late Phase I/R Injury or Rejection after Orthotopic Liver Transplantation
176. 488 Protein Level and Gene Promoter Polymorphism of Matrilysin (Mmp-7) Are Independent Prognostic Factors for Survival of Colorectal Cancer Patients
177. S1802 Relevance of Matrix Metalloproteinase (MMP)-2 and MMP-9 Gene Promoter Polymorphisms in Ischemia/Reperfusion Injury and Rejection After Orthotopic Liver Transplantation
178. M2073 NOD2/CARD15, Toll-Like Receptor 4, and Toll-Like Receptor 9 Gene Polymorphisms in Spanish and Dutch Patients with Inflammatory Bowel Disease
179. Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer
180. Phosphoprotein Keratin 23 accumulates in MSS but not MSI colon cancersin vivoand impacts viability and proliferationin vitro
181. Infliximab treatment influences the serological expression of matrix metalloproteinase (MMP)-2 and -9 in Crohnʼs disease
182. 5-ASA and Colorectal Cell-Cycle Progression
183. Low prevalence of Helicobacter pylori infection in young children in the Netherlands
184. Effect of the anti-tumor necrosis factor-α antibody infliximab on the ex vivo mucosal matrix metalloproteinase–proteolytic phenotype in inflammatory bowel disease
185. High peak alanine aminotransferase determines extra risk for nonanastomotic biliary strictures after liver transplantation with donation after circulatory death.
186. Role of Tumor Necrosis Factor-alpha and Interleukin-10 Gene Polymorphisms in Irritable Bowel Syndrome
187. Reply
188. Proteases as prognostic markers in cancer: proteolytic enzymes and their inhibitors influence the spread of cancer
189. Preanalytical Conditions and Circulating Matrix Metalloproteinases
190. ASSESSMENT OF SERUM MATRIX METALLOPROTEINASES MMP-2 AND MMP-9 AFTER HUMAN LIVER TRANSPLANTATION: INCREASED SERUM MMP-9 LEVEL IN ACUTE REJECTION
191. Differential mucosal expression of three superoxide dismutase isoforms in inflammatory bowel disease
192. Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease
193. Intestinal oxidative damage in inflammatory bowel disease: semi‐quantification, localization, and association with mucosal antioxidants
194. Leucocyte matrix metalloproteinase (MMP)-9 gene and protein regulation in Crohn's disease
195. Contribution to the regulation of intestinal matrix metalloProteinase expression by tumor necrosis factor alpha in inflammatory bowel disease
196. The expression of receptors for vasoactive intestinal peptide and secretin in colon neoplasms
197. CuZn superoxide dismutase (SOD1) accumulates in vacuolated mitochondria in transgenic mice expressing amyotrophic lateral sclerosis-linked SOD1 mutations
198. Expression of receptors for vasoavtive intestinal peptide, secretin and somatostatin in colorectal cancer
199. Metallothionein in human gastrointestinal cancer
200. Collagen degradation and neutrophilic infiltration: a vicious circle in inflammatory bowel disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.